ME00563A - Postupak za pripremanje optički aktivnih jedinjenja - Google Patents

Postupak za pripremanje optički aktivnih jedinjenja

Info

Publication number
ME00563A
ME00563A MEP-848/08A MEP84808A ME00563A ME 00563 A ME00563 A ME 00563A ME P84808 A MEP84808 A ME P84808A ME 00563 A ME00563 A ME 00563A
Authority
ME
Montenegro
Prior art keywords
optically pure
active compounds
pure active
preparing optically
chiral
Prior art date
Application number
MEP-848/08A
Other languages
English (en)
Inventor
Bernhard Kohl
Bernd Mueller
Ralf Steffen Weingart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ME00563A publication Critical patent/ME00563A/bs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Pronalazak se odnosi na novi postupak za pripremanje opti čki čistog PPI koji ima sulfi nalnu strukturu upotrebom hiralnog kompleksa cirkonijuma ili hiralnog kompleksa hafnijuma.
MEP-848/08A 2002-12-06 2003-12-03 Postupak za pripremanje optički aktivnih jedinjenja ME00563A (bs)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02027273 2002-12-06
DE10340255 2003-08-29
YU20050423A RS52667B (sr) 2002-12-06 2003-12-03 Postupak za pripremanje optički čistih jedinjenja
PCT/EP2003/013605 WO2004052882A1 (en) 2002-12-06 2003-12-03 Process for preparing optically pure active compounds

Publications (1)

Publication Number Publication Date
ME00563A true ME00563A (bs) 2011-12-20

Family

ID=32509784

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-848/08A ME00563A (bs) 2002-12-06 2003-12-03 Postupak za pripremanje optički aktivnih jedinjenja

Country Status (27)

Country Link
US (1) US7452998B2 (bs)
EP (1) EP1578742B1 (bs)
JP (1) JP4612542B2 (bs)
KR (1) KR101062806B1 (bs)
CN (1) CN100482658C (bs)
AR (1) AR042277A1 (bs)
AU (1) AU2003289948B2 (bs)
BR (2) BRPI0310118B1 (bs)
CA (1) CA2507807C (bs)
CY (1) CY1114058T1 (bs)
DK (1) DK1578742T3 (bs)
EA (1) EA011771B1 (bs)
ES (1) ES2397380T3 (bs)
HR (1) HRP20050604B1 (bs)
IL (1) IL168456A (bs)
IS (1) IS2885B (bs)
ME (1) ME00563A (bs)
MX (1) MXPA05005762A (bs)
NO (1) NO330978B1 (bs)
NZ (1) NZ540815A (bs)
PL (1) PL375818A1 (bs)
PT (1) PT1578742E (bs)
RS (1) RS52667B (bs)
SI (1) SI1578742T1 (bs)
TW (1) TWI313268B (bs)
WO (1) WO2004052882A1 (bs)
ZA (1) ZA200503543B (bs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Healthcare Llc .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
AU2003293749B2 (en) 2002-12-06 2009-12-24 Takeda Gmbh Process for preparing (S)-pantoprazole
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US7507829B2 (en) * 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
MXPA05013316A (es) * 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
BRPI0511515A (pt) * 2004-06-02 2007-12-26 Altana Pharma Ag processo para a preparação de compostos de piridin-2-ilmetilsulfinil-1h-benzimidazol
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
CA2570795C (en) * 2004-06-24 2013-05-28 Astrazeneca Ab Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
CA2660112A1 (en) * 2006-08-08 2008-02-14 Jubilant Organosys Limited Process for producing sulphoxide compounds
EP2065379A4 (en) 2006-10-13 2011-01-19 Eisai R&D Man Co Ltd BENZIMIDAZOLE HAVING INHIBITORY ACTIVITY OF GASTRIC ACID SECRETION
AU2007317561A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CN101977909A (zh) * 2008-03-18 2011-02-16 雷迪博士实验室有限公司 右兰索拉唑方法和多晶型物
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
EP2264024A1 (en) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Process for the preparation of enantiomerically enriched proton pump inhibitors
US8071781B2 (en) 2008-11-11 2011-12-06 Syn-Tech Chem. & Pharm. Co., Ltd. Process for preparing rabeprazole sodium
EP2534144B1 (en) 2010-02-12 2014-09-03 Esteve Química, S.A. Preparation process of the sodium salt of Esomeprazole
CN103113351B (zh) * 2013-03-08 2015-01-21 苏州特瑞药业有限公司 一种光学纯手性亚砜类化合物的制备方法
CN103936714A (zh) * 2014-04-15 2014-07-23 北京华禧联合科技发展有限公司 一种埃索美拉唑镁的制备方法
US10307748B2 (en) 2014-12-26 2019-06-04 The University Of Tokyo Method for producing proton pump inhibitor compound having optical activity
CN105440018A (zh) * 2015-11-27 2016-03-30 福州闽海药业有限公司 一种锆催化的右旋兰索拉唑的不对称氧化合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
SE465514B (sv) 1990-02-19 1991-09-23 Curt Pettersson Foerfarande och anvaendning av ett separationsmedium vid separation av enantiomerer
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
JPH08509738A (ja) 1993-04-27 1996-10-15 セプラコー，インコーポレイテッド 光学的に純粋な（＋）パントプラゾールを用いる胃の疾患治療の方法と組成
AU6713194A (en) 1993-04-27 1994-11-21 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
AU2003293749B2 (en) 2002-12-06 2009-12-24 Takeda Gmbh Process for preparing (S)-pantoprazole

Also Published As

Publication number Publication date
TW200508219A (en) 2005-03-01
RS52667B (sr) 2013-06-28
JP4612542B2 (ja) 2011-01-12
NZ540815A (en) 2008-03-28
BRPI0310118B1 (pt) 2015-10-20
KR101062806B1 (ko) 2011-09-07
ZA200503543B (en) 2006-08-30
CN1717403A (zh) 2006-01-04
IS7909A (is) 2005-06-23
EA200500898A1 (ru) 2005-12-29
US7452998B2 (en) 2008-11-18
DK1578742T3 (da) 2013-01-21
CN100482658C (zh) 2009-04-29
JP2006516261A (ja) 2006-06-29
KR20050085224A (ko) 2005-08-29
HK1078864A1 (en) 2006-03-24
RS20050423A (sr) 2007-04-10
CA2507807C (en) 2013-10-22
WO2004052882A1 (en) 2004-06-24
BR0317005A (pt) 2005-10-25
NO20053099L (no) 2005-06-24
AU2003289948B2 (en) 2009-12-24
EA011771B1 (ru) 2009-06-30
HRP20050604B1 (hr) 2013-09-30
MXPA05005762A (es) 2005-08-16
PT1578742E (pt) 2013-01-24
TWI313268B (en) 2009-08-11
SI1578742T1 (sl) 2013-02-28
HRP20050604A2 (en) 2006-09-30
IS2885B (is) 2014-07-15
NO20053099D0 (no) 2005-06-24
IL168456A (en) 2012-02-29
PL375818A1 (en) 2005-12-12
NO330978B1 (no) 2011-08-29
ES2397380T3 (es) 2013-03-06
EP1578742B1 (en) 2012-10-17
AR042277A1 (es) 2005-06-15
CA2507807A1 (en) 2004-06-24
US20050288334A1 (en) 2005-12-29
EP1578742A1 (en) 2005-09-28
AU2003289948A1 (en) 2004-06-30
CY1114058T1 (el) 2016-07-27

Similar Documents

Publication Publication Date Title
HRP20050604B1 (hr) Postupak priprave optiäśki äśistih aktivnih spojeva
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
CU23337B7 (es) Resolución de sal quiral
FR2889526B1 (fr) 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
DE60329237D1 (de) Kristalline form von linezolid
CO6190512A2 (es) Compuestos antagonistas del receptor de glucagon composiciones que contienen dichos compuestos y procedimientos de uso
ATE440999T1 (de) Verbesserungen betreffend optische aufheller
DE60112956T2 (de) Kristalline formen von fluvastatin sodium
BR0316702A (pt) xprocesso para preparação de (s)-pantoprazol
DE60319707D1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
DE50312430D1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
BRPI0416678A (pt) pirazolpirimidinas
PA8515201A1 (es) Compuestos y composiciones antipicornavirales; sus usos farmaceuticos y los materiales para su sintesis
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
DE502005011199D1 (de) Herstellung eines von willenbrand faktor-präparates mit hoher spezifischer aktivität
DE69300453D1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
GT200200219A (es) Bencimidazoles
DE502004009136D1 (de) NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb
DE602004006021D1 (de) Verfahren zur racematspaltung von nefopam
ATE502007T1 (de) Synthese von optisch reinem (r)-5-(2-aminopropyl)-2-methoxybenzolsulphonami
ATE282726T1 (de) Herstellung von verbindungen auf basis von cu-in- se phasengleichgewichten
DE602004014739D1 (de) Chemoenzymatisches verfahren zur stereoselektiven herstellung von optisch-angereicherten phenylglycidate
UY27448A1 (es) Ésteres de análogos de 3-desoxi-vitamina d3
DE602004007048D1 (de) Verfahren zur Herstellung von optisch aktiven Verbindungen